World Prescription Dermatological Drugs Market, 10th Edition (Antiacne & Rosacea, Antiaging & Photodamage, Dermatitis & Seborrhea, Antifungal, Hair Loss & Hair Removal, Hyperpigmentation/Melasma & Depigmenting, Psoriasis, and Skin Cancer Drug Market)

 
   Single User - $4,200
   Site License (one location, 10 users) - $6,300
   Corporate License - $8,400



Loading...
Published Jun 14, 2017 | 414 Pages | Pub ID: KLI15384768

World Prescription Dermatological Drugs Market, 10th Edition (Antiacne and Rosacea, Antiaging and Photodamage, Dermatitis and Seborrhea, Antifungal, Hair Loss and Hair Removal, Hyperpigmentation/Melasma and Depigmenting, Psoriasis, Skin Cancer, and Miscellaneous Skin Disorder Drug Market)

World Prescription Dermatological Drugs Market, 10th Edition (Antiacne and Rosacea, Antiaging and Photodamage, Dermatitis and Seborrhea, Antifungal, Hair Loss and Hair Removal, Hyperpigmentation/Melasma and Depigmenting, Psoriasis, Skin Cancer, and Miscellaneous Skin Disorder Drug Market)

The field of dermatology is currently experiencing a busy and interesting period and, as a result, the range of therapeutic options available to physicians has expanded. World Prescription Dermatological Drugs Market takes an inclusive look at many different areas of dermatology and prescription dermatology products. This area of medicine has blossomed due to an increase in skin cancer incidence, new exciting biologics for psoriasis, increased demand by baby boomers -both men and women - for antiaging products, consolidation within the industry, and strong late stage pipeline entities.

World Prescription Dermatological Drugs Market, 10th Edition's market data provide multiple year forecasts for different product segments within the worldwide market for prescription dermatological drugs, including the following world markets:
  • Worldwide Market for Prescription Acne and Rosacea Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Antiaging and Photodamage Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Dermatitis and Seborrhea Drugs by Type, 2016-2021
  • Worldwide Market for Prescription Antifungal Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Hair Loss and Hair Removal Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Psoriasis Drugs by Type, 2014-2021
  • Worldwide Market for Skin Cancer Drugs by Type, 2014-2021
  • Worldwide Market for Prescription Miscellaneous Skin Disorder Drugs by Type, 2014-2021

Markets by Geographical Region

The worldwide opportunity for prescription dermatology products is dominated by several key markets, including the United States, Europe, Japan, and rest of world. Penetration within any of the prescription dermatological drugs segments is based on the incidence and prevalence in different regions. Level of demand may be based on any number of factors including epidemiology (i.e., skin color), economic conditions, reimbursement issues, and availability of generic products. The report provides the following prescription dermatology drug data points:
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Australia, and Other ROW Prescription Acne and Rosacea Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Australia, and Other ROW Prescription Antiaging and Photodamage Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Australia, and Other ROW Dermatitis and Seborrhea Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Australia, and Other ROW Antifungal Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, ROW, China, India, Brazil, Russia, and Other ROW Hair Loss and Hair Removal Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, China, India, Brazil, Russia, and ROW Hyperpigmentation/Melasma and Depigmenting Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, China, India, Brazil, Australia, and ROW Psoriasis Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, China, India, Brazil, Australia, and ROW Skin Cancer Drugs Market, 2016-2021
  • US, Europe, Germany, France, UK, Italy, Spain, Other European, Japan, China, South Korea, Brazil, Russia, and ROW Miscellaneous Skin Disorder Drugs Market, 2016-2021

Market Issues and Trends

There are numerous issues that are shaping the direction of the field of dermatology. Advancements in technology and knowledge of the disease process are influencing the research and development efforts of the industry, along with the decisions of what products to pursue.

This is an exciting time in dermatology as there continues to be a shift in the understanding of the pathophysiology of many skin diseases. Some of the most exciting new developments in dermatology include:
  • New biologics and their uses in dermatology
  • Movement towards dispensing prescription dermatology agents in the office
  • Growth in platelet rich plasma

Competitive Market Analysis

Demand in the prescription dermatology products market will likely remain high due to the aging population and the quest for lifestyle treatments to meet the needs of aging baby boomers. There are a number of companies participating in the worldwide market for prescription dermatological drugs, ranging from large international pharmaceutical companies, small niche pharmaceutical companies, to generic companies both large and small. There is also competitive pressure in this market from over-the-counter (OTC) participants. However, even with the availability of OTC products, manufacturers of prescription products continue to do well in terms of revenues.

Competitor Profiles

World Prescription Dermatological Drugs Market provides revenues and market share by supplier for 2016 by market segment. In addition corporate profiles of the following prescription dermatological drugs market competitors are provided:
  • AbbVie, Inc.
  • Allergan
  • Almirall, S.A.
  • Amgen, Inc.
  • Anacor Pharmaceuticals, Inc.
  • Astellas Pharma, Inc.
  • Basilea Pharmaceutica Ltd.
  • Bayer
  • Biofrontera AG
  • Bristol-Myers Squibb
  • Cipher Pharmaceuticals
  • Cutanea Life Sciences
  • Dermira, Inc.
  • Galderma S.A.
  • Genentech
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • LEO Pharma A/S
  • Maruho Co. Ltd.
  • Merck & Company
  • Merz Pharma GmbH & Co KGaA
  • Mylan N.V.
  • Novan, Inc.
  • Novartis Pharmaceuticals Corporation
  • Pfizer, Inc.
  • PharmaDerm
  • Sienna Biopharmaceuticals, Inc.
  • Sinclair Pharma Plc.
  • Stiefel
  • Valeant Pharmaceuticals International
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.